Scholars Central

Research articlePublished 2016

Subcutaneous Nodules during Treatment with an Exenatide Long-Actin Once-Weekly Formulation: An Ultrasound Evaluation

Authors: Felice Strollo

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Lipodystrophy (LD) represents a typical complication of drug injections repeatedly performed into the same skin area and/or needle reuse and is a major complication of subcutaneous therapy, including lipohypertrophy and lipoatrophy. It has been associated to insulin, as well as, to a number of other drugs as pegvisomant, TNFα inhibitors and glucagon-like peptide-1 receptor agonists (GLP1-Ras) including exenatide and its longacting once-weekly formulation (EQW) as already reported in specific registration studies. Accordingly, this article provided the ultrasound documentation of subcutaneous nodules occurring after EQW injections in a series of 56 diabetic subjects and described a possible association between the ultrasonography structures of observed lesions and missing injection site rotation. This was similar to what already reported with respect to skin lipohypertrophy and inappropriate insulin injection techniques.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Diversity & Equality in Health and Care.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiversity & Equality in Health and Care
  • SubjectRadiology & Imaging
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Felice Strollo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels